ConforMIS Inc (NASDAQ:CFMS) has earned an average rating of “Hold” from the eight analysts that are presently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $5.70.
CFMS has been the subject of a number of research reports. BTIG Research upgraded shares of ConforMIS from a “neutral” rating to a “buy” rating and set a $4.00 price target for the company in a report on Wednesday, December 20th. JPMorgan Chase & Co. cut shares of ConforMIS from a “neutral” rating to an “underweight” rating in a report on Tuesday, January 2nd. Finally, Zacks Investment Research cut shares of ConforMIS from a “buy” rating to a “hold” rating in a report on Tuesday, October 31st.
In other news, insider David Cerveny sold 16,392 shares of ConforMIS stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $3.17, for a total transaction of $51,962.64. Following the completion of the transaction, the insider now directly owns 151,408 shares in the company, valued at $479,963.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Paul S. Weiner sold 17,723 shares of ConforMIS stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $3.17, for a total transaction of $56,181.91. Following the transaction, the chief financial officer now owns 162,009 shares of the company’s stock, valued at $513,568.53. The disclosure for this sale can be found here. Insiders sold 83,248 shares of company stock valued at $235,021 over the last 90 days. Corporate insiders own 9.55% of the company’s stock.
Shares of ConforMIS (NASDAQ:CFMS) opened at $2.33 on Friday. ConforMIS has a 12-month low of $2.21 and a 12-month high of $8.61. The company has a debt-to-equity ratio of 0.52, a quick ratio of 5.38 and a current ratio of 6.19. The firm has a market cap of $110.06, a price-to-earnings ratio of -1.74 and a beta of 2.21.
ConforMIS (NASDAQ:CFMS) last posted its quarterly earnings data on Wednesday, November 1st. The medical instruments supplier reported ($0.29) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.32) by $0.03. The company had revenue of $18.40 million during the quarter, compared to analysts’ expectations of $17.55 million. ConforMIS had a negative net margin of 72.70% and a negative return on equity of 76.88%. ConforMIS’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.31) earnings per share. research analysts anticipate that ConforMIS will post -1.27 EPS for the current year.
ConforMIS, Inc is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient’s anatomy. The Company’s iFit technology platform is applicable to various joints.
Receive News & Ratings for ConforMIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS and related companies with MarketBeat.com's FREE daily email newsletter.